Flow of payments for a 400 USD insulin with high deductible patient 2017
This statistic shows the flow of payments for a hypothetical insulin that costs 400 U.S. dollars while the patient has health coverage with a high deductible from the employer, as of 2017. According to the source, in such a case, the manufacturer retains 88 U.S. dollars while the health insurance plan/plan sponsor retains 239 dollars.
